Literature DB >> 22976078

3xTg-AD mice exhibit an activated central stress axis during early-stage pathology.

Elaine K Hebda-Bauer1, Tracy A Simmons, Andrew Sugg, Eren Ural, James A Stewart, James L Beals, Qiang Wei, Stanley J Watson, Huda Akil.   

Abstract

Activation of the hypothalamic-pituitary-adrenal (HPA) axis occurs in response to the organism's innate need for homeostasis. The glucocorticoids (GCs) that are released into the circulation upon acute activation of the HPA axis perform stress-adaptive functions and provide negative feedback to turn off the HPA axis, but can be detrimental when in excess. Long-term activation of the HPA axis (such as with chronic stress) enhances susceptibility to neuronal dysfunction and death, and increases vulnerability to Alzheimer's disease (AD). However, little is known how components of the HPA axis, upstream of GCs, impact vulnerability to AD. This study examined basal gene expression of stress-related molecules in brains of 3xTg-AD mice during early-stage pathology. Basal GC levels and mRNA expression of the glucocorticoid receptor (GR), mineralocorticoid receptor (MR), and corticotropic releasing hormone (CRH) in several stress- and emotionality-related brain regions were measured in 3-4-month-old 3xTg-AD mice. Despite normal GC levels, young 3xTg-AD mice exhibit an activated central HPA axis, with altered mRNA levels of MR and GR in the hippocampus, GR and CRH in the paraventricular nucleus of the hypothalamus, GR and CRH in the central nucleus of the amygdala, and CRH in the bed nucleus of the stria terminalis. This HPA axis activation is present during early-stage neuropathology when 3xTg-AD mice show mild behavioral changes, suggesting an ongoing neuroendocrine regulation that precedes the onset of severe AD-like pathology and behavioral deficits.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22976078      PMCID: PMC3525735          DOI: 10.3233/JAD-2012-121438

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  71 in total

1.  Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice.

Authors:  Grace E Stutzmann; Ian Smith; Antonella Caccamo; Salvatore Oddo; Frank M Laferla; Ian Parker
Journal:  J Neurosci       Date:  2006-05-10       Impact factor: 6.167

2.  The amyloidogenic potential and behavioral correlates of stress.

Authors:  C Catania; I Sotiropoulos; R Silva; C Onofri; K C Breen; N Sousa; O F X Almeida
Journal:  Mol Psychiatry       Date:  2007-10-02       Impact factor: 15.992

3.  Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.

Authors:  Yoelvis García-Mesa; Juan Carlos López-Ramos; Lydia Giménez-Llort; Susana Revilla; Rafael Guerra; Agnès Gruart; Frank M Laferla; Rosa Cristòfol; José M Delgado-García; Coral Sanfeliu
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

4.  Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior.

Authors:  J D Shepard; K W Barron; D A Myers
Journal:  Brain Res       Date:  2000-04-10       Impact factor: 3.252

5.  Ventral subicular interaction with the hypothalamic paraventricular nucleus: evidence for a relay in the bed nucleus of the stria terminalis.

Authors:  W E Cullinan; J P Herman; S J Watson
Journal:  J Comp Neurol       Date:  1993-06-01       Impact factor: 3.215

Review 6.  Brain corticosteroid receptor balance in health and disease.

Authors:  E R De Kloet; E Vreugdenhil; M S Oitzl; M Joëls
Journal:  Endocr Rev       Date:  1998-06       Impact factor: 19.871

7.  Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice.

Authors:  Shreaya Chakroborty; Ivan Goussakov; Megan B Miller; Grace E Stutzmann
Journal:  J Neurosci       Date:  2009-07-29       Impact factor: 6.167

8.  Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease.

Authors:  Marisa Srivareerat; Trinh T Tran; Karem H Alzoubi; Karim A Alkadhi
Journal:  Biol Psychiatry       Date:  2008-10-11       Impact factor: 13.382

9.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08

10.  Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APPV717I-CT100 transgenic mice, an Alzheimer's disease model.

Authors:  Yun Ha Jeong; Cheol Hyoung Park; Jongman Yoo; Ki Young Shin; Sung-Min Ahn; Hye-Sun Kim; Sang Hyung Lee; Piers C Emson; Yoo-Hun Suh
Journal:  FASEB J       Date:  2006-02-08       Impact factor: 5.191

View more
  24 in total

1.  Autoimmune manifestations in the 3xTg-AD model of Alzheimer's disease.

Authors:  Monica Marchese; David Cowan; Elizabeth Head; Donglai Ma; Khalil Karimi; Vanessa Ashthorpe; Minesh Kapadia; Hui Zhao; Paulina Davis; Boris Sakic
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

2.  Subchronic glucocorticoid receptor inhibition rescues early episodic memory and synaptic plasticity deficits in a mouse model of Alzheimer's disease.

Authors:  Fabien Lanté; Magda Chafai; Elisabeth Fabienne Raymond; Ana Rita Salgueiro Pereira; Xavier Mouska; Scherazad Kootar; Jacques Barik; Ingrid Bethus; Hélène Marie
Journal:  Neuropsychopharmacology       Date:  2015-01-27       Impact factor: 7.853

3.  Posttraumatic stress disorder-like induction elevates β-amyloid levels, which directly activates corticotropin-releasing factor neurons to exacerbate stress responses.

Authors:  Nicholas J Justice; Longwen Huang; Jin-Bin Tian; Allysa Cole; Melissa Pruski; Albert J Hunt; Rene Flores; Michael X Zhu; Benjamin R Arenkiel; Hui Zheng
Journal:  J Neurosci       Date:  2015-02-11       Impact factor: 6.167

4.  Heightened Tameness and Accelerated Handling-Habituation in 3×Tg-AD Mice on a B6;129 Genetic Background.

Authors:  Wen Hu; Chun-Ling Dai; Jiahui Niu; Khalid Iqbal
Journal:  J Alzheimers Dis Rep       Date:  2022-05-23

5.  Icariin ameliorates memory deficits through regulating brain insulin signaling and glucose transporters in 3×Tg-AD mice.

Authors:  Fei Yan; Ju Liu; Mei-Xiang Chen; Ying Zhang; Sheng-Jiao Wei; Hai Jin; Jing Nie; Xiao-Long Fu; Jing-Shan Shi; Shao-Yu Zhou; Feng Jin
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

6.  Anxiety-like behavior as an early endophenotype in the TgF344-AD rat model of Alzheimer's disease.

Authors:  Nathan S Pentkowski; Laura E Berkowitz; Shannon M Thompson; Emma N Drake; Carlos R Olguin; Benjamin J Clark
Journal:  Neurobiol Aging       Date:  2017-10-05       Impact factor: 4.673

Review 7.  Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review.

Authors:  Erwin Lemche
Journal:  Curr Genomics       Date:  2018-11       Impact factor: 2.236

Review 8.  Anxiety and Alzheimer's disease: Behavioral analysis and neural basis in rodent models of Alzheimer's-related neuropathology.

Authors:  Nathan S Pentkowski; Kimberly K Rogge-Obando; Tia N Donaldson; Samuel J Bouquin; Benjamin J Clark
Journal:  Neurosci Biobehav Rev       Date:  2021-05-09       Impact factor: 9.052

Review 9.  Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?

Authors:  Xin Du; Terence Y Pang
Journal:  Front Psychiatry       Date:  2015-03-09       Impact factor: 4.157

10.  Locus Coeruleus, norepinephrine and Aβ peptides in Alzheimer's disease.

Authors:  Jennifer A Ross; Paul McGonigle; Elisabeth J Van Bockstaele
Journal:  Neurobiol Stress       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.